Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne A Efebera

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Blood|June 28, 2014
It is time to move forward with Waldenström!Yvonne A Efebera
Cancers|March 11, 2023
Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer TherapyNidhi Sharma, Yvonne A Efebera
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Fixed-Duration Versus Until Disease Progression: How Long Should Initial Treatment of Multiple Myeloma Last?Yvonne A Efebera, Nina Shah
European Journal of Case Reports in Internal Medicine|February 17, 2015
Long-Term Therapy with Lenalidomide in a Patient with POEMS SyndromeBenjamin F Chu, Arwa Shana'ah, Craig C Hofmeister, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myelomaOmar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
International Journal of Bone Marrow Research|June 3, 2021
Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)Yvonne A Efebera, Amy S Ruppert, Apollinaire Ngankeu, et al.
Haematologica|November 30, 2023
Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non- Hispanic White race/ethnicity in the United StatesTondre Buck, Monique A Hartley-Brown, Yvonne A Efebera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector FunctionNina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Leukemia|April 22, 2018
Ninety-minute daratumumab infusion is safe in multiple myelomaHallie Barr, Jessica Dempsey, Allyson Waller, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Blood|June 28, 2014
It is time to move forward with Waldenström!Yvonne A Efebera
Cancers|March 11, 2023
Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer TherapyNidhi Sharma, Yvonne A Efebera
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Fixed-Duration Versus Until Disease Progression: How Long Should Initial Treatment of Multiple Myeloma Last?Yvonne A Efebera, Nina Shah
European Journal of Case Reports in Internal Medicine|February 17, 2015
Long-Term Therapy with Lenalidomide in a Patient with POEMS SyndromeBenjamin F Chu, Arwa Shana'ah, Craig C Hofmeister, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myelomaOmar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
International Journal of Bone Marrow Research|June 3, 2021
Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)Yvonne A Efebera, Amy S Ruppert, Apollinaire Ngankeu, et al.
Haematologica|November 30, 2023
Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non- Hispanic White race/ethnicity in the United StatesTondre Buck, Monique A Hartley-Brown, Yvonne A Efebera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector FunctionNina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Leukemia|April 22, 2018
Ninety-minute daratumumab infusion is safe in multiple myelomaHallie Barr, Jessica Dempsey, Allyson Waller, et al.
Pageof 7